Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Intravenous and Intrathecal Onasemnogene Abeparvovec Gene Therapy in Symptomatic and Presymptomatic Spinal Muscular Atrophy: Long-Term Follow-Up Study

              Author:Darras, Basil   Mercuri, Eugenio   Strauss, Kevin   Day, John   Chien, Yin-Hsiu   Masson, Ricardo   Wigderson, Melissa   Alecu, Iulian   Ballarini, Nicolas   Mehl, Lesa   Marra, Jonathan   Connolly, Anne   

              Session Name:S34: Child Neurology and Developmental Neurology 2  

              Topic:Child Neurology and Developmental Neurology  

              Program Number:S34.002  

              Author Institution:Boston Children’s Hospital, Harvard Medical School, Boston, MA  Department of Paediatric Neurology and Nemo Clinical Centre, Catholic University, Rome, Italy  Clinic for Special Children, Strasburg, PA  Stanford University School of Medicine, Palo Alto, CA  National Taiwan University Hospital, Taipei City, Taiwan  Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy  Novartis Gene Therapies, Inc., Bannockburn, IL  Novartis Pharmaceuticals, Basel, Switzerland  Novartis Institutes for BioMedical Research, Cambridge, MA  Novartis Pharmaceuticals, East Hanover, NJ  Center for Gene Therapy, Nationwide Children's Hospital, Columbus, OH  

              Pre-Treatment Cephalic Interictal Allodynia Predicts Outcome of Prophylactic Treatment of Chronic and Episodic Migraine Patients with Galcanezumab: A Prospective Quantitative Sensory Testing Study

              Author:Ashina, Sait   Melo-Carrillo, Agustin   Szabo, Edina   Borsook, David   Burstein, Rami   

              Session Name:S47: Advances in Migraine Therapeutics  

              Topic:Headache  

              Program Number:S47.008  

              Author Institution:Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA  Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA  Boston Children’s Hospital, Harvard Medical School, Boston, MA  Massachusetts General Hospital, Harvard Medical School, Boston, MA  Beth Isreal Deacones Medical Center, Boston, MA  

              Bulbar Function in Children with Two or Three SMN2 Copies Who Received Onasemnogene Abeparvovec Presymptomatically for Spinal Muscular Atrophy

              Author:McGrattan, Katlyn   Shell, Richard   Hurst-Davis, Rebecca   Dunaway Young, Sally   Baranello, Giovanni   Lavrov, Arseniy   O'Brien, Eamonn   Wallach, Shiri   LaMarca, Nicole   Reyna, Sandra P.   Darras, Basil   

              Session Name:P7: Child Neurology and Developmental Neurology: Spinomuscular Atrophy/Muscular Dystrophies  

              Topic:Child Neurology and Developmental Neurology  

              Program Number:P7.008  

              Author Institution:University of minnesota, Minneapolis, MN  Nationwide Children’s Hospital and Department of Pediatrics, The Ohio State University, Columbus, OH  Primary Children’s Hospital, Salt Lake City, UT  Stanford University School of Medicine, Stanford, CA  The Dubowitz Neuromuscular Centre, Developmental Neuroscience Research and Teaching Department, UCL Great Ormond Street Institute of Child Health and NIHR Great Ormond Street Hospital Biomedical Research Centre & Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom  Novartis Gene Therapies, Inc., Cambridge, United Kingdom  Novartis, Dublin, Ireland  Novartis Gene Therapies, Inc., Bannockburn, IL  Boston Children’s Hospital, Harvard Medical School, Boston, MA  

              Fenfluramine Treatment Is Associated With Improvement in Everyday Executive Function in Adults With Lennox-Gastaut Syndrome: Post-Hoc Analysis of Dose Effects From a Phase 3 Trial Rationale

              Author:Bishop, Kim   Isquith, Peter   Knupp, Kelly   Sullivan, Joseph   Nabbout, Rima   Gil-Nagel, Antonio   Scheffer, Ingrid   Auvin, Stéphane   Cross, J Helen   Guerrini, Renzo   Roth, Robert   Gioia, Gerard   Lothe, Amélie   Polega, Shikha   

              Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P11.001  

              Author Institution:Global Pharma Consultancy, LLC, Muncy, PA  Global Pharma Consultancy, LLC  Boston Children’s Hospital, Harvard Medical School, Boston, MA  Children's Hospital Colorado, Aurora, CO  University of California San Francisco, Benioff Children’s Hospital, San Francisco, CA  Reference Centre for Rare Epilepsies, Hôpital Universitaire Necker-Enfants Malades, APHP, Member of EPICARE, Institut Imagine, Université Paris Cité, Paris, France  Hospital Ruber Internacional, Madrid, Spain  University of Melbourne, Austin Hospital and Royal Children’s Hospital, Florey Institute and Murdoch Children’s Research Institute, Heidelberg, Australia  Robert Debré University Hospital, APHP, Université de Paris, Institut Universitaire de France (IUF), Paris, France  UCL NIHR BRC Great Ormond Street Institute of Child Health, London, United Kingdom  Anna Meyer Children's Hospital, University of Florence, Milan, Italy  Dartmouth-Hitchcock Medical Center, Lebanon, NH  Children’s National Health System, Rockville, MD  Zogenix International (now a part of UCB), Maidenhead, United Kingdom  Zogenix, Inc. (now a part of UCB), Emeryville, CA